Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform Bill Gets Cool Reception From Rx Industry; Damage Cap Is Worry

Executive Summary

A new patent reform bill introduced in Congress is likely to undergo revisions in the face of criticism from the pharmaceutical industry

You may also be interested in...



House Focuses On Patent Reform, Other IP Issues With New Judiciary Subcommittee

Patent reform will be a priority for incoming House Judiciary Committee Chairman Lamar Smith, R.-Texas, who has created a subcommittee to spearhead development of legislation to protect Americans' intellectual assets.

House Focuses On Patent Reform, Other IP Issues With New Judiciary Subcommittee

Patent reform will be a priority for incoming House Judiciary Committee Chairman Lamar Smith, R.-Texas, who has created a subcommittee to spearhead development of legislation to protect Americans' intellectual assets.

Full House Judiciary Panel Getting Into The Patent Act: IP Issues Will No Longer Go Through Subcmte.

Change in jurisdiction eliminates one round of legislative review, gives Chairman Conyers direct control of issue.

Related Content

UsernamePublicRestriction

Register

PS048285

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel